Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: Apalutamide and androgen deprivation therapy for the treatment of high-risk localized prostate cancer following radical prostatectomy in Apa-RP: a multicenter, open-label, single-arm phase
